{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:03:52Z","timestamp":1793199832369,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.fitote.2020.104482","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T11:30:33Z","timestamp":1579174233000},"page":"104482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["A review on osteoclast diseases and osteoclastogenesis inhibitors recently developed from natural resources"],"prefix":"10.1016","volume":"142","author":[{"given":"Xiaoyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Mitsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fitote.2020.104482_bb0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature."},{"key":"10.1016\/j.fitote.2020.104482_bb0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.fitote.2020.104482_bb0015","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1073\/pnas.95.23.13835","article-title":"Dissociation between bone resorption and bone formation in osteopenic transgenic mice","volume":"95","author":"Corral","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.fitote.2020.104482_bb0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1534-5807(02)00157-0","article-title":"Reaching a genetic and molecular understanding of skeletal development","volume":"2","author":"Karsenty","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.fitote.2020.104482_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1874847300902010037","article-title":"Methyl Ganoderic acid DM: a selective potent osteoclastogenesis inhibitor","volume":"7","author":"Liu","year":"2009","journal-title":"Open Bioact. Compd. J."},{"key":"10.1016\/j.fitote.2020.104482_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","author":"Kong","year":"1999","journal-title":"Nature."},{"key":"10.1016\/j.fitote.2020.104482_bb0035","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin \/ osteoclastogenesis-inhibitory factor and is identical to TRANCE \/ RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.fitote.2020.104482_bb0040","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.fitote.2020.104482_bb0045","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1182\/blood-2008-06-162594","article-title":"PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts","volume":"113","author":"Hikata","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.fitote.2020.104482_bb0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.fitote.2020.104482_bb0055","doi-asserted-by":"crossref","first-page":"20551","DOI":"10.1074\/jbc.273.32.20551","article-title":"Characterization of the intracellular domain of receptor activator of NF-\u03baB (RANK)","volume":"273","author":"Darnay","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fitote.2020.104482_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL-RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.fitote.2020.104482_bb0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1196\/annals.1346.014","article-title":"M-CSF, c-Fms, and signaling in osteoclasts and their precursors","volume":"1068","author":"Ross","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.fitote.2020.104482_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/np500663y","article-title":"Magnolol inhibits RANKL-induced osteoclast differentiation of RAW 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression","volume":"78","author":"Lu","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.fitote.2020.104482_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2008.11.005","article-title":"Regulation of osteoclastogenesis by ganoderic acid DM isolated from Ganoderma lucidum","volume":"602","author":"Miyamoto","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fitote.2020.104482_bb0080","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.fitote.2020.104482_bb0085","doi-asserted-by":"crossref","first-page":"18245","DOI":"10.1074\/jbc.M610701200","article-title":"NF-kB p50 and p52 regulate receptor activator of NF-kB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating-Fos and NFATc1","volume":"282","author":"Yamashita","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fitote.2020.104482_bb0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1196\/annals.1402.071","article-title":"The role of NFAT in osteoclast formation","volume":"1116","author":"Takayanagi","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.fitote.2020.104482_bb0095","doi-asserted-by":"crossref","first-page":"41147","DOI":"10.1074\/jbc.M205063200","article-title":"Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator","volume":"277","author":"Ishida","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fitote.2020.104482_bb0100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bone.2007.05.016","article-title":"Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells","volume":"41","author":"Mohamed","year":"2007","journal-title":"Bone."},{"key":"10.1016\/j.fitote.2020.104482_bb0105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0959-437X(00)00228-8","article-title":"Genetic control of skeletal development","volume":"11","author":"Wagner","year":"2001","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.fitote.2020.104482_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell."},{"key":"10.1016\/j.fitote.2020.104482_bb0115","first-page":"36","article-title":"Ethnic difference in osteoporosis-related phenotypes and its potential underlying genetic determination","volume":"6","author":"Lei","year":"2006","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.fitote.2020.104482_bb0120","first-page":"265","article-title":"Prevention and treatment of osteoporosis with Chinese herbal medicines","volume":"4","author":"Xiao-ling","year":"2012","journal-title":"Chinese Herb. Med."},{"key":"10.1016\/j.fitote.2020.104482_bb0125","first-page":"1163","article-title":"Osteoclastogenesis inhibitory effect of ergosterol peroxide isolated from Pleurotus eryngii","volume":"7","author":"Yokoyama","year":"2012","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.fitote.2020.104482_bb0130","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/jf402735u","article-title":"Inhibitory effects of the leaves of loquat (Eriobotrya japonica) on bone mineral density loss in ovariectomized mice and osteoclast differentiation","volume":"62","author":"Tan","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.fitote.2020.104482_bb0135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/molecules14010573","article-title":"Antiosteoporotic activity of anthraquinones from Morinda officinalis on osteoblasts and osteoclasts","volume":"14","author":"Wu","year":"2009","journal-title":"Molecules."},{"key":"10.1016\/j.fitote.2020.104482_bb0140","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.fitote.2020.104482_bb0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11914-007-0024-y","article-title":"The RANKL\/RANK\/OPG pathway","volume":"5","author":"Boyce","year":"2007","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.fitote.2020.104482_bb0150","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3892\/mmr.2015.3152","article-title":"Receptor activator of nuclear factor-\u03baB ligand (RANKL)\/RANK\/osteoprotegerin system in bone and other tissues (review)","volume":"11","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.fitote.2020.104482_bb0155","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis\u202f: concepts , conflicts , and prospects find the latest version\u202f: science in medicine pathogenesis of osteoporosis\u202f: concepts , conflicts , and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.fitote.2020.104482_bb0160","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0015-0282(16)55848-8","article-title":"Osteoporosis: screening, prevention and management","volume":"59","author":"Notelovitz","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.fitote.2020.104482_bb0165","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fitote.2020.104482_bb0170","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#","article-title":"Activated human T cells directly induce osteoclastogenesis from human monocytes","volume":"44","author":"Kotake","year":"2001","journal-title":"Arthritis Rheum. Off. J. Am. Coll. Rheumatol."},{"key":"10.1016\/j.fitote.2020.104482_bb0175","first-page":"2050","article-title":"Adult Paget\u2019s disease of bone: a review","volume":"56","author":"Tuck","year":"2017","journal-title":"Rheumatol. (United Kingdom)."},{"key":"10.1016\/j.fitote.2020.104482_bb0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00223-012-9599-0","article-title":"Pathogenesis of Paget disease of bone","volume":"91","author":"Ralston","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.fitote.2020.104482_bb0185","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1172\/JCI9133","article-title":"Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget\u2019s disease of bone","volume":"105","author":"Menaa","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.fitote.2020.104482_bb0190","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/path.1953","article-title":"Bone stromal cells in pagetic bone and Paget\u2019s sarcoma express RANKL and support human osteoclast formation","volume":"209","author":"Sun","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.fitote.2020.104482_bb0195","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI8489","article-title":"Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype","volume":"105","author":"Kurihara","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.fitote.2020.104482_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2017.00234","article-title":"Key triggers of osteoclast-related diseases and available strategies for targeted therapies: a review","volume":"4","author":"Bi","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.fitote.2020.104482_bb0205","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1172\/JCI24281","article-title":"Science in medicine-Paget disease of bone","volume":"115","author":"Roodman","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.fitote.2020.104482_bb0210","first-page":"69","article-title":"Giant-cell tumor of bone: treatment options and role of denosumab","volume":"9","author":"Singh","year":"2015","journal-title":"Biol. Targets Ther."},{"key":"10.1016\/j.fitote.2020.104482_bb0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0002-9440(10)62959-8","article-title":"Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor \u03baB","volume":"167","author":"Morgan","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.fitote.2020.104482_bb0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lab.2004.06.005","article-title":"Gene expression in giant-celltumors","volume":"144","author":"Skubitz","year":"2004","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.fitote.2020.104482_bb0225","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1359\/jbmr.2000.15.4.640","article-title":"Expression of osteoclast differentiation signals by stromal elements of giant cell tumors","volume":"15","author":"Atkins","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.fitote.2020.104482_bb0230","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00003086-200112000-00007","article-title":"Wear and periprosthetic osteolysis","volume":"393","author":"Harris","year":"2001","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.fitote.2020.104482_bb0235","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.arth.2003.09.001","article-title":"Long-term follow-up care recommendations after total hip and knee arthroplasty: results of the American association of hip and knee surgeons\u2019 member survey","volume":"18","author":"Teeny","year":"2003","journal-title":"J. Arthroplasty."},{"key":"10.1016\/j.fitote.2020.104482_bb0240","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.arth.2010.04.026","article-title":"Quality of life outcomes in revision versus primary total knee arthroplasty","volume":"26","author":"Greidanus","year":"2011","journal-title":"J. Arthroplast."},{"key":"10.1016\/j.fitote.2020.104482_bb0245","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9440(10)65266-2","article-title":"Tumor necrosis factor-\u03b1 mediates orthopedic implant osteolysis","volume":"154","author":"Merkel","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.fitote.2020.104482_bb0250","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1016\/j.biomaterials.2004.01.053","article-title":"The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts","volume":"25","author":"Pioletti","year":"2004","journal-title":"Biomaterials."},{"key":"10.1016\/j.fitote.2020.104482_bb0255","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.biomaterials.2006.05.054","article-title":"The correlation of RANK, RANKL and TNF\u03b1 expression with bone loss volume and polyethylene wear debris around hip implants","volume":"27","author":"Holding","year":"2006","journal-title":"Biomaterials."},{"key":"10.1016\/j.fitote.2020.104482_bb0260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.blo.0000238813.95035.1b","article-title":"The cellular and molecular biology of periprosthetic osteolysis","author":"Purdue","year":"2007","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.fitote.2020.104482_bb0265","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1016\/j.actbio.2013.05.005","article-title":"Osteolysis around total knee arthroplasty: a review of pathogenetic mechanisms","volume":"9","author":"Gallo","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.fitote.2020.104482_bb0270","first-page":"S1","article-title":"NCCN task force report: bone health in cancer care","volume":"7","author":"Julie","year":"2009","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.fitote.2020.104482_bb0275","first-page":"2692","article-title":"Bisphosphonates : mechanisms of action","volume":"97","author":"Rodan","year":"1996","journal-title":"Endocrine."},{"key":"10.1016\/j.fitote.2020.104482_bb0280","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.0.CO;2-Q","article-title":"The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma","volume":"88","author":"Carlin","year":"2000","journal-title":"Cancer."},{"key":"10.1016\/j.fitote.2020.104482_bb0285","first-page":"1300","article-title":"A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 trial)","volume":"95","author":"Dearnaley","year":"2003","journal-title":"CancerSpectrum Knowl. Environ."},{"key":"10.1016\/j.fitote.2020.104482_bb0290","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1525832","article-title":"The current role of osteoclast inhibitors in patients with prostate cancer","volume":"2018","author":"Kozyrakis","year":"2018","journal-title":"Adv. Urol."},{"key":"10.1016\/j.fitote.2020.104482_bb0295","first-page":"377","article-title":"Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind comparative trial","volume":"7","author":"Rosen","year":"2001","journal-title":"Cancer J."},{"key":"10.1016\/j.fitote.2020.104482_bb0300","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1158\/1078-0432.CCR-13-2275","article-title":"Comparative efficacy of bisphosphonates in metastatic breast and prostate cancer and multiple myeloma: a mixed-treatment meta-analysis","volume":"19","author":"Palmieri","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.fitote.2020.104482_bb0305","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bone.2011.02.011","article-title":"Bisphosphonates for postmenopausal osteoporosis","volume":"49","author":"Eastell","year":"2011","journal-title":"Bone."},{"key":"10.1016\/j.fitote.2020.104482_bb0310","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10067-009-1256-2","article-title":"Pamidronate treatment in rheumatology practice: a comprehensive review","volume":"28","author":"Slobodin","year":"2009","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.fitote.2020.104482_bb0315","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/SPC.0b013e328349dc17","article-title":"Antitumor effects of bisphosphonates: from the laboratory to the clinic","volume":"5","author":"Berenson","year":"2011","journal-title":"Curr. Opin. Support. Palliat. Care."},{"key":"10.1016\/j.fitote.2020.104482_bb0320","first-page":"1233","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates. Discussion over 52 cases","volume":"52","author":"Alm\u01ce\u015fan","year":"2011","journal-title":"Romanian J. Morphol. Embryol."},{"key":"10.1016\/j.fitote.2020.104482_bb0325","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/qjmed\/hcs112","article-title":"Incidence of serious side effects with intravenous bisphosphonate: a clinical audit","volume":"105","author":"Powell","year":"2012","journal-title":"Qjm."},{"key":"10.1016\/j.fitote.2020.104482_bb0330","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.fitote.2020.104482_bb0335","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.oraloncology.2007.11.012","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies","volume":"44","author":"Boonyapakorn","year":"2008","journal-title":"Oral Oncol."},{"key":"10.1016\/j.fitote.2020.104482_bb0340","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s002239900353","article-title":"An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates","volume":"61","author":"Thi\u00e9baud","year":"1997","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.fitote.2020.104482_bb0345","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/107999003322558782","article-title":"Fever after zoledronic acid administration is due to increase in TNF-\u03b1 and IL-6","volume":"23","author":"Dicuonzo","year":"2003","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.fitote.2020.104482_bb0350","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00223-010-9364-1","article-title":"Adverse effects of bisphosphonates","volume":"86","author":"Abrahamsen","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.fitote.2020.104482_bb0355","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10787-013-0183-7","article-title":"Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments","volume":"21","author":"Muralidharan","year":"2013","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.fitote.2020.104482_bb0360","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bone.2010.10.161","article-title":"Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis","volume":"48","author":"Lipton","year":"2011","journal-title":"Bone."},{"key":"10.1016\/j.fitote.2020.104482_bb0365","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.fitote.2020.104482_bb0370","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000358258","article-title":"Management of bone metastases in patients with castration-resistant prostate cancer","volume":"92","author":"Cathomas","year":"2014","journal-title":"Urol. Int."},{"key":"10.1016\/j.fitote.2020.104482_bb0375","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","article-title":"2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary","volume":"182","author":"Atkinson","year":"2010","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.fitote.2020.104482_bb0380","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(11)61226-9","article-title":"Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial","volume":"379","author":"Smith","year":"2012","journal-title":"Lancet."},{"key":"10.1016\/j.fitote.2020.104482_bb0385","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00774-015-0677-z","article-title":"Severe hypercalcemia following denosumab treatment in a juvenile patient","volume":"34","author":"Setsu","year":"2016","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.fitote.2020.104482_bb0390","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.fitote.2020.104482_bb0395","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jc.2013-1143","article-title":"Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile paget\u2019s disease","volume":"98","author":"Grasemann","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.fitote.2020.104482_bb0400","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/pbc.25393","article-title":"Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone","volume":"62","author":"Gossai","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.fitote.2020.104482_bb0405","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.fitote.2020.104482_bb0410","series-title":"Medication Guide: Prolia\u00ae (PR\u00d3-lee-a) (denosumab) Injection, for Subcutaneous Use","year":"2020"},{"key":"10.1016\/j.fitote.2020.104482_bb0415","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S8756-3282(02)00953-5","article-title":"The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts","volume":"32","author":"Bord","year":"2003","journal-title":"Bone."},{"key":"10.1016\/j.fitote.2020.104482_bb0420","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-fatourechi","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.fitote.2020.104482_bb0425","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the women\u2019s health initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.fitote.2020.104482_bb0430","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1006250213357","article-title":"Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer","volume":"56","author":"Pyrh\u00f6nen","year":"1999","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.fitote.2020.104482_bb0435","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s002239900714","article-title":"Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer","volume":"65","author":"Marttunen","year":"1999","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.fitote.2020.104482_bb0440","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1359\/jbmr.2003.18.3.473","article-title":"The effects of tamoxifen and toremifene on bone cells involve changes in plasma membrane ion conductance","volume":"18","author":"Lehenkari","year":"2003","journal-title":"J. Bone Miniral Res."},{"key":"10.1016\/j.fitote.2020.104482_bb0445","first-page":"558","article-title":"Adverse events reported by postmenopausal women in controlled trials with raloxifene","volume":"93","author":"Davies","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.fitote.2020.104482_bb0450","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.fitote.2020.104482_bb0455","doi-asserted-by":"crossref","first-page":"127","DOI":"10.11620\/IJOB.2013.38.3.127","article-title":"Xylitol down-regulates 1\u03b1,25-dihydroxy vitamin D3-induced osteoclastogenesis via in part the inhibition of RANKL expression in osteoblasts","volume":"38","author":"Ohk","year":"2013","journal-title":"Int. J. Oral Biol."},{"key":"10.1016\/j.fitote.2020.104482_bb0460","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00253-012-4146-5","article-title":"Mycoepoxydiene suppresses RANKL-induced osteoclast differentiation and reduces ovariectomy-induced bone loss in mice","volume":"97","author":"Zhu","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.fitote.2020.104482_bb0465","first-page":"1","article-title":"Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-\u03baB pathway and attenuating ROS production","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fitote.2020.104482_bb0470","first-page":"169","article-title":"The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells","volume":"29","author":"Kim","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.fitote.2020.104482_bb0475","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.foodchem.2008.09.001","article-title":"Chemical studies of anthocyanins: a review","volume":"113","author":"Casta\u00f1eda-Ovando","year":"2009","journal-title":"Food Chem."},{"key":"10.1016\/j.fitote.2020.104482_bb0480","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2008.10.012","article-title":"(\u2212)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency","volume":"1250","author":"Lee","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.fitote.2020.104482_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2019.104280","article-title":"Identification and structure-activity relationship (SAR) of chemical constituents from Daemonorops draco (Willd.) Blume and selected commercial flavonoids on anti-osteoclastogenesis activity","volume":"138","author":"Wang","year":"2019","journal-title":"Fitoterapia."},{"key":"10.1016\/j.fitote.2020.104482_bb0490","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1016\/j.bmcl.2010.06.118","article-title":"Inhibitors of osteoclastogenesis from Lawsonia inermis leaves","volume":"20","author":"Cuong","year":"2010","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.fitote.2020.104482_bb0495","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0891-5849(00)00302-6","article-title":"Triggering and modulation of apoptosis by oxidative stress","volume":"29","author":"Chandra","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.fitote.2020.104482_bb0500","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2003.10.032","article-title":"Activation of ERK1\/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: role of ERK1\/2 in H2O2-induced cell death","volume":"483","author":"Ruffels","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fitote.2020.104482_bb0505","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2007.01.089","article-title":"Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells","volume":"564","author":"Zhang","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fitote.2020.104482_bb0510","doi-asserted-by":"crossref","first-page":"F440","DOI":"10.1152\/ajprenal.00170.2006","article-title":"ERK promotes hydrogen peroxide-induced apoptosis through caspase-3 activation and inhibition of Akt in renal epithelial cells","volume":"292","author":"Zhuang","year":"2007","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.fitote.2020.104482_bb0515","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s11064-008-9860-0","article-title":"Neuroprotective effects of ugonin K on hydrogenperoxide-induced cell death in human neuroblastoma SH-SY5Y cells","volume":"34","author":"Lin","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.fitote.2020.104482_bb0520","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.biocel.2008.10.029","article-title":"Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway","volume":"41","author":"Chen","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.fitote.2020.104482_bb0525","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/10799893.2013.839999","article-title":"Taurine exerts anti-osteoclastogenesis activity via inhibiting ROS generation, JNK phosphorylation and COX-2 expression in RAW264.7 cells","volume":"33","author":"Jang","year":"2013","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.fitote.2020.104482_bb0530","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/jcm7100345","article-title":"Effect of usnic acid on osteoclastogenic activity","volume":"7","author":"Kim","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.fitote.2020.104482_bb0535","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejphar.2016.08.012","article-title":"Diarylheptanoid from Curcuma comosa Roxb. Suppresses RANKL-induced osteoclast differentiation by decreasing NFATc1 and c-Fos expression via MAPK pathway","volume":"788","author":"Chawalitpong","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fitote.2020.104482_bb0540","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/jcm7060154","article-title":"Betulin suppresses osteoclast formation via down-regulating NFATc1","volume":"7","author":"Kim","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.fitote.2020.104482_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2015.10.027","article-title":"Chaetocin inhibits RANKL-induced osteoclast differentiation through reduction of Blimp1 in Raw264 7 cells","volume":"143","author":"Zhao","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.fitote.2020.104482_bb0550","first-page":"6721","article-title":"Antibacterial, anti-inflammatory, and anti-osteoclastogenesis roles of allicin in periodontitis","volume":"11","author":"Guan","year":"2018","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.fitote.2020.104482_bb0555","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biopha.2017.06.059","article-title":"Alpinumisoflavone inhibits osteoclast differentiation and exerts anti-osteoporotic effect in ovariectomized mice","volume":"93","author":"Cong","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fitote.2020.104482_bb0560","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/jcp.26575","article-title":"Abietic acid attenuates RANKL induced osteoclastogenesis and inflammation associated osteolysis by inhibiting the NF-KB and MAPK signaling","volume":"234","author":"Thummuri","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.fitote.2020.104482_bb0565","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.clim.2014.09.014","article-title":"Pristimerin, a naturally occurring triterpenoid, protects against autoimmune arthritis by modulating the cellular and soluble immune mediators of inflammation and tissue damage","volume":"155","author":"Tong","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.fitote.2020.104482_bb0570","doi-asserted-by":"crossref","first-page":"35081","DOI":"10.1074\/jbc.C500353200","article-title":"Regulation of the transcriptional activity of c-Fos by ERK: a novel role for the prolyl isomerase Pin1","volume":"280","author":"Monje","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fitote.2020.104482_bb0575","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1083\/jcb.148.2.333","article-title":"Reciprocal role of ERK and NF-\u03baB pathways in survival and activation of osteoclasts","volume":"148","author":"Miyazaki","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.fitote.2020.104482_bb0580","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fct.2013.08.047","article-title":"Xanthohumol modulates the expression of osteoclast-specific genes during osteoclastogenesis in RAW264.7 cells","volume":"62","author":"Suh","year":"2013","journal-title":"Food Chem. Toxicol."},{"issue":"17650","key":"10.1016\/j.fitote.2020.104482_bb0585","article-title":"Inhibition of Osteoclastogenesis and Bone resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fitote.2020.104482_bb0590","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.bcp.2009.10.010","article-title":"3,3\u2032-Diindolylmethane attenuates experimental arthritis and osteoclastogenesis","volume":"79","author":"Dong","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.fitote.2020.104482_bb0595","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.1021\/acs.jafc.7b03666","article-title":"Sophoridine from sophora flower attenuates ovariectomy induced osteoporosis through the RANKL-ERK-NFAT pathway","volume":"65","author":"Zhao","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.fitote.2020.104482_bb0600","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bonr.2015.10.003","article-title":"Massive elimination of multinucleated osteoclasts by eupatilin is due to dual inhibition of transcription and cytoskeletal rearrangement","volume":"3","author":"Kim","year":"2015","journal-title":"Bone Reports."},{"key":"10.1016\/j.fitote.2020.104482_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113698","article-title":"Jatrorrhizine hydrochloride suppresses RANKL-induced osteoclastogenesis and protects against wear particle-induced osteolysis","volume":"19","author":"Li","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fitote.2020.104482_bb0610","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.7150\/ijbs.12152","article-title":"Norisoboldine, an anti-arthritis alkaloid isolated from Radix linderae, attenuates osteoclast differentiation and inflammatory bone erosion in an aryl hydrocarbon receptor-dependent manner","volume":"11","author":"Wei","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.fitote.2020.104482_bb0615","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00198-016-3496-8","article-title":"Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis","volume":"27","author":"Dou","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.fitote.2020.104482_bb0620","first-page":"1","article-title":"Hesperetin revents pone resorption by inhibiting RANKL-induced osteoclastogenesis and Jnk mediated Irf-3\/c-Jun activation","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fitote.2020.104482_bb0625","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1096\/fj.201701148RR","article-title":"Tetrandrine attenuates the bone erosion in collagen-induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase","volume":"32","author":"Jia","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.fitote.2020.104482_bb0630","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phymed.2014.10.008","article-title":"Mollugin from Rubea cordifolia suppresses receptor activator of nuclear factor-\u03baB ligand-induced osteoclastogenesis and bone resorbing activity in vitro and prevents lipopolysaccharide-induced bone loss in vivo","volume":"22","author":"Baek","year":"2014","journal-title":"Phytomedicine."},{"key":"10.1016\/j.fitote.2020.104482_bb0635","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ptr.5565","article-title":"Protocatechuic acid attenuates osteoclastogenesis by downregulating JNK\/c-Fos\/NFATc1 signaling and prevents inflammatory bone loss in mice","volume":"30","author":"Park","year":"2016","journal-title":"Phyther. Res."},{"key":"10.1016\/j.fitote.2020.104482_bb0640","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2012.08.013","article-title":"The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-kB in collagen-induced arthritis and bone marrow-derived macrophages","volume":"698","author":"Jeong-eun","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fitote.2020.104482_bb0645","first-page":"582","article-title":"Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-\u03baB and JNK signalling pathways","volume":"44","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.fitote.2020.104482_bb0650","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bone.2014.06.023","article-title":"Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications for breast cancer bone metastasis","volume":"66","author":"Haider","year":"2014","journal-title":"Bone."},{"key":"10.1016\/j.fitote.2020.104482_bb0655","doi-asserted-by":"crossref","first-page":"L1005","DOI":"10.1152\/ajplung.2000.279.6.L1005","article-title":"Reactive oxygen species in cell signaling","volume":"279","author":"Thannickal","year":"2018","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"10.1016\/j.fitote.2020.104482_bb0660","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.yexcr.2004.07.035","article-title":"Reactive oxygen species mediate RANK signaling in osteoclasts","volume":"301","author":"Ha","year":"2004","journal-title":"Exp. Cell Res."}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X20300642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X20300642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:20:31Z","timestamp":1759796431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X20300642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":132,"alternative-id":["S0367326X20300642"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2020.104482","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on osteoclast diseases and osteoclastogenesis inhibitors recently developed from natural resources","name":"articletitle","label":"Article Title"},{"value":"Fitoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fitote.2020.104482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104482"}}